- Investor's Business Daily•3 days ago
Potential blockbuster combo drugs from Sanofi and Novo Nordisk are near launch, and reducing death rates may be next battleground.
- Market Realist•13 days ago
The European Medicines Agency’s CHMP gave positive recommendations to seven medicines for the extension of therapeutic indications in its June meeting.
Novo Nordisk A/SNYSE
After hours: 55.14-0.16 (-0.30%) as of 5:16 PM EDT
|Bid||55.19 x 100|
|Ask||55.77 x 100|
|52wk Range||46.17 - 60.34|
|Day's Range||54.69 - 55.44|
|Avg Vol (3m)||1,341,779|
As of 4:02 PM EDT. Market closed.